Stan E. Abel

Stan E. Abel joined SiteOne in February 2014 as President and Chief Executive Officer, bringing to the company more than 20 years of senior management and financial experience. Mr. Abel's background includes successfully leading complex development-stage life science companies, identifying and in-licensing important new pharmaceutical product opportunities, raising more than $100M in capital to fund operations, and providing strategic advisory services to a wide range of development stage biotech companies. Mr. Abel currently serves as a member of the board directors of Adynxx, Inc.

Mr. Abel served as Chief Executive Officer of Corthera, Inc., from October 2007 through the successful sale of the company to Novartis in February 2010. Prior to joining Corthera, he was a founder and Chief Financial Officer of Cerexa, Inc. from its inception in July 2005 through the successful sale of the company to Forest Laboratories in January 2007. Prior to Cerexa‚ he was the Chief Financial Officer of Peninsula Pharmaceuticals, Inc. from January 2003 through the sale of the company to Johnson & Johnson in June 2005.

Earlier in his career‚ Mr. Abel spent four years at Eli Lilly and Company within the finance and strategy organizations. He also held a variety of financial leadership positions during his nine years at DowBrands‚ Inc., a wholly-owned subsidiary of The Dow Chemical Company. He earned a B.S. in business from Indiana University and an M.B.A.‚ with honors‚ from the University of Chicago. He received his CPA from the State of Indiana in 1995.